Metabolomics analysis of hormone-responsive and triple-negative breast cancer cell responses to paclitaxel identify key metabolic differences
DA Stewart, JH Winnike, SL McRitchie… - Journal of proteome …, 2016 - ACS Publications
To date, no targeted therapies are available to treat triple negative breast cancer (TNBC),
while other breast cancer subtypes are responsive to current therapeutic treatment …
while other breast cancer subtypes are responsive to current therapeutic treatment …
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.
DA Stewart, JH Winnike, SL McRitchie… - Journal of Proteome …, 2016 - europepmc.org
To date, no targeted therapies are available to treat triple negative breast cancer (TNBC),
while other breast cancer subtypes are responsive to current therapeutic treatment …
while other breast cancer subtypes are responsive to current therapeutic treatment …
[HTML][HTML] Metabolomics analysis of hormone-responsive and triple-negative breast cancer cell responses to paclitaxel identify key metabolic differences
DA Stewart, JH Winnike, SL McRitchie… - Journal of proteome …, 2016 - ncbi.nlm.nih.gov
To date, no targeted therapies are available to treat triple negative breast cancer (TNBC),
while other breast cancer subtypes are responsive to current therapeutic treatment …
while other breast cancer subtypes are responsive to current therapeutic treatment …
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
DA Stewart, JH Winnike… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
To date, no targeted therapies are available to treat triple negative breast cancer (TNBC),
while other breast cancer subtypes are responsive to current therapeutic treatment …
while other breast cancer subtypes are responsive to current therapeutic treatment …
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.
DA Stewart, JH Winnike, SL McRitchie… - Journal of Proteome …, 2016 - europepmc.org
To date, no targeted therapies are available to treat triple negative breast cancer (TNBC),
while other breast cancer subtypes are responsive to current therapeutic treatment …
while other breast cancer subtypes are responsive to current therapeutic treatment …